Table 2.

Estimated effects of mindfulness and worry on average post-injection fatigue, focus problems, and memory problems

Outcome	Injection type	Change for +1 SD increase in mindfulness (95% CI)	p-value	Change for +1 SD increase in PSWQ (95% CI)	p-value
Fatigue	Placebo	−0.46 (−0.69, −0.22)	.0001	0.20 (−0.05, 0.44)	.12
	Vaccine	−0.25 (−0.48, −0.01)	.04	0.16 (−0.08, 0.39)	.19
	Averaged	−0.35 (−0.54, −0.16)	.0004	0.18 (-0.03, 0.38)	.09
Focus	Placebo	−0.26 (−0.46, −0.07)	.008	0.32 (0.10, 0.54)	.004
	Vaccine	−0.43 (−0.67, −0.19)	.0004	0.43 (0.18, 0.68)	.0008
	Averaged	−0.35 (−0.54, −0.16)	.0003	0.37 (0.17, 0.58)	.0004
Memory	Placebo	−0.14 (−0.35, 0.07)	.19	0.22 (0.04, 0.40)	.02
	Vaccine	−0.36 (−0.58, −0.14)	.001	0.39 (0.17, 0.62)	.0006
	Averaged	−0.25 (−0.44, −0.06)	.01	0.31 (0.13, 0.49)	.0009

Models adjusted for: age, cancer treatment, hormone treatment, obesity, depression, physical fitness, visit order, cancer stage, time since cancer treatment, and presence of comorbidities.